// App-Quantinova.ai

75 : Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer

Researchers

Presenter

  • Dante Bortone

Principal Investigators

  • Sarah Entwistle

  • Alexandria Cogdill

  • Anne Monette

  • Yana Najjar

  • Randy Sweis

  • Nicholas Tschernia

  • Erik Wennerberg

  • Praveen Bommareddy

  • Cara Haymaker

  • Uqba Khan

  • Heather McGee

  • Wungki Park

  • Houssein Sater

  • Christine Spencer

  • Maria Ascierto

  • Valentin Barsan

  • Vinita Popat

  • Sara Valpione

  • Danny Wells

  • Vsteinn Thorsson

  • Roberta Zappasodi

  • Nils Rudqvist

  • Benjamin Vincent

Medical Centers

  • University of North Carolina, Chapel Hill, NC

  • The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA

  • Jewish General Hospital/ McGill Univeristy, Montreal, QC, Canada

  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA

  • The Institute of Cancer Research, London, UK

  • Replimune, Woburn, MA, USA

  • Memorial Sloan Kettering Cancer Center, Sterling Heights, MI, USA

  • Salk Institute for Biological Sciences, New York, NY, USA

  • National Cancer Institute, Bethesda, MD

  • Parker Institute for Cancer Immunotherapy, San Francisco, CA

  • AstraZeneca, Gaithersburg, MD

  • Stanford University School of Medicine, La Jolla, CA, USA

  • University of Manchester, Manchester, United Kingdom

  • Parker Institute for Cancer Immunotherapy, San Francisco, CA

  • Institute of Systems Biology, Seattle, Washington, USA

  • Weill Cornell Medicine, New York, NY

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Solid malignancies

  • STAR syndrome

Biomarkers

  • Programmed cell death protein 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved